Filing Details
- Accession Number:
- 0001209191-21-020416
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-15 14:47:40
- Reporting Period:
- 2021-03-15
- Accepted Time:
- 2021-03-15 14:47:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1160308 | Savara Inc | SVRA | Pharmaceutical Preparations (2834) | 841318182 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1408498 | L David Lowrance | 6836 Bee Cave Road Building Iii, Suite 200 Austin TX 787846 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-15 | 13,793 | $1.45 | 13,793 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
